TheProfitWatch

ALEC - Alector, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.2 0.06 (5.42%) --- 0.0 (0.0%) -0.01 (-0.39%) --- 0.06 (5.42%) --- ---

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.3
Diluted EPS:
-0.3
Basic P/E:
-4.2167
Diluted P/E:
-4.2167
RSI(14) 1m:
50.0
VWAP:
1.27
RVol:

Events

Period Kind Movement Occurred At

Related News